Skip to content

Vasomotor Symptom Alleviation Through Acupuncture in Patients With Prostate Cancer

Vasomotor Symptom Alleviation Through Acupuncture in Patients With Prostate Cancer

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06472856
Acronym
VASA Pro
Enrollment
12
Registered
2024-06-25
Start date
2024-08-30
Completion date
2025-10-07
Last updated
2026-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

A pilot study to assess the acceptability and efficacy of acupuncture in alleviating vasomotor symptoms (hot flushes and night sweats) in Irish patients with prostate cancer receiving androgen deprivation therapy.

Interventions

PROCEDUREAcupuncture

Acupuncture will be given using single use sterile stainless steel 34 gauge (Japanese size: 0.20 X 30 mm) filoform needles. Skin will be swabbed with an alcohol prep pad before acupuncture is administered. Needles will be inserted 0.5 to 1.0 centimetres deep into the skin and gently manipulated to create the deqi sensation. No electrical stimulation will be used.

Sponsors

University College Cork
Lead SponsorOTHER
Bon Secours Hospital, Cork
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All participants must have a histologically confirmed diagnosis of prostate cancer and currently be treated with androgen deprivation therapy with or without additional prostate cancer therapies. * Patients under the care of a Medical Oncologist in either Bons Secours Hospital or Cork University Hospital * All participants must be experiencing moderate to severe vasomotor symptoms as defined by a score of 4 or more on the Hot Flash Index.

Exclusion criteria

* Patients under 18. * Patients with HFI scores below 4. * Patients not currently being treated with androgen deprivation therapy. * Patients with contraindications to acupuncture. * Patients already receiving acupuncture for vasomotor symptoms. * Patients unwilling to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the interventionCompleted after 6 weeks of acupuncture sessions and repeated 3 months after acupuncture has finishedSpecially designed questionnaire

Secondary

MeasureTime frameDescription
Changes in symptom interference scoresCompleted after 6 weeks of acupuncture sessions and repeated 3 months after acupuncture has finishedChanges in the Hot Flash Related Daily Interference Scale (HFRDIS). The scale is measured from 0-10, with lower scores indicating a better outcomes
Changes in sleep qualityCompleted after 6 weeks of acupuncture sessions and repeated 3 months after acupuncture has finishedChanges in Pittsburgh Sleep Quality Index (PSQI). Each answer is rated between 0-3, and a higher global score indicates a worse outcome.

Countries

Ireland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026